Current news

April 5, 2021

BioStem Technologies today reported financial results for the three and twelve months ended December 31, 2020
Read MoreRead More

March 25, 2021

BioStem announced that it has received the TRIP (TRG Rapid Inquiry Program) response from the FDA’s Tissue Reference Group (TRG) for the Company’s amniotic membrane allograft, VENDAJE™
Read MoreRead More

March 15, 2021

BioStem Technologies, Inc. announced it engaged D. Brooks and Associates CPA's, P.A. as the Company’s PCAOB registered certified public accounting firm for the 2020 and 2019 fiscal years.
Read MoreRead More

December 24, 2020

BioStem Technologies today announced that it has filed its quarterly reports for 2020 to become current with OTC Markets.
Read MoreRead More

Subscribe To Our Newsletter

To stay up to date on all of our news, products, and achievements, please subscribe to our newsletter

Contact Information
(954) 380-8342

2836 Center Port Circle
Pompano Beach, FL 33064




© 2021 BioStem Technologies, Inc. All Rights Reserved. Use of this site is subject to certain Terms Of Use and Privacy Policy.
For screen reader problems with this website, please call (954) 380-8342 for assistance.